HomeTrialNCT07247110
🔬NCT07247110Phase 1RECRUITING

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

Study Summary

Researchers are looking for new ways to treat certain advanced or metastatic solid tumors. The goal of this study is to learn about the safety of MK-4716 and if people tolerate it when taken alone or with other treatments.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment250 participants
Primary Completion
Lead SponsorMerck Sharp & Dohme LLC
Data Retrieved2026-04-11 02:55:36.204882+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.